Differences of resected hepatocellular carcinoma with hepatitis B or C virus

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1722-1725

  Shuto, Taichi ^a   Hirohashi, Kazuhiro ^a   Kubo, Shoji ^a   Tsukamoto, Tadashi ^a   Yamamoto, Takatsugu ^a   Wakasa, Kenichi ^b   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinicopathological findings; Hepatic resection; Hepatitis virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR VOLUME; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0031736809     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62.
2. Shiratori Y, Shiina S, Imamura M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology 1995; 22:1027-33.
3. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH: Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19:222-6.
4. Suga M, Senota A, Arima K, et al: Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma. Hepato-Gastroenterology 1994; 41:438-41.
5. Trevisani F, D'Intino PE, Caraceni P, et al: Etiologic factors and clinical presentation of hepatocellular carcinoma. Cancer 1995; 75:2220-32.
6. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathological features and results of surgical treatment. Ann Surg 1990; 211:277-87.
7. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S: Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases. Hepato-Gastroenterology 1993; 40:328-32.
8. Colombo M, Kuo G, Choo QL, et al: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 28:1006-8.
9. Bruix J, Barrera JM, Calvet X, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 28:1004-6.
10. Okuda K, Fujimoto I, Hayashi A, Urano Y: Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47:4967-72.
11. Kaneko S, Urano M, Takeuchi M, et al: The role of hepatitis C virus in hepatocellular carcinoma in Japan. Intervirology 1994; 37:108-13.
12. Kiyosato K, Sodeyama T, Tanaka E, et al: Interrelationship of blood transfusion, non-A, non-B hepatitis hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671-5.
13. Ikeda K, Saitoh S, Koida I, et al: A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47-53.